Abstract
It is estimated that about 2.5 million people are living with HIV infection in India. Although antiretroviral drugs have been able to reduce the mortality, these drugs have serious side effects one of which is lipodystrophy syndrome. Most of the drugs used in HAART viz, protease inhibitors, stavudine and nevirapine are associated with lipodystrophy. Hence we conducted this study to assess the prevalence of lipodystrophy in HIV infected children on HAART and its associated risk factors. A cross sectional study was conducted on 80 HIV infected children aged 2-18 years of age who were on stavudine based HAART for ≥ 2 years. These children were assessed for presence of lipodystrophy, its metabolic complications and associated risk factors. Lipodystrophy was observed in 33.7% of children with lipoatrophy being the commonest subtype followed by lipohypertrophy. Older age, increased duration of treatment and dyslipidaemia were found to be associated in patients with lipodystrophy than those without. On further multivariate analysis of independent risk factors only increased duration of treatment was significantly associated with lipodystrophy. No association was found with insulin resistance. We observed that lipodystrophy is a common finding in HIV patients treated with HAART for long duration.
Highlights
HIV infection is increasingly becoming a prominent cause of morbidity and mortality with an estimated 2.5 million people living with HIV in India [1]
The median time since HAART was first initiated was 4.75 ± 1.49 (2-7 years) and all patients were on stavudine based HAART
All three forms of fat redistribution was observed of which lipoatrophy was commonest (n=18, 66.6%) followed by lipohypertrophy (n=3, 11.1%) and African Health sciences Vol 14 No 2 June 2014 combined subtype (n=6, 22.2%)
Summary
HIV infection is increasingly becoming a prominent cause of morbidity and mortality with an estimated 2.5 million people living with HIV in India [1]. The term Lipodystrophy syndrome was first used to describe morphological complications of these drugs in HIV infected adults. We conducted this study to assess the prevalence of fat redistribution and its associated risk factors in our tertiary care centre. We conducted this study to assess the prevalence of lipodystrophy in HIV infected children on HAART and its associated risk factors. Materials and methods: A cross sectional study was conducted on 80 HIV infected children aged 2-18 years of age who were on stavudine based HAART for ≥2 years. These children were assessed for presence of lipodystrophy, its metabolic complications and associated risk factors. Conclusion: We observed that lipodystrophy is a common finding in HIV patients treated with HAART for long duration
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
